Time course of sputum positivity during chemotherapy in smear-positive pumonary tuberculosis

V. A. M. Martino, R. M. Refini, G. Ciarleglio, L. Scarsella, R. Amerini, P. Sestini (Siena, Italy)

Source: Annual Congress 2001 - What can treatment of TB achieve?
Session: What can treatment of TB achieve?
Session type: Poster Discussion
Number: 2248
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. A. M. Martino, R. M. Refini, G. Ciarleglio, L. Scarsella, R. Amerini, P. Sestini (Siena, Italy). Time course of sputum positivity during chemotherapy in smear-positive pumonary tuberculosis. Eur Respir J 2001; 16: Suppl. 31, 2248

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Response to empirical anti-tuberculosis treatment in patients with sputum smear-negative pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 845s
Year: 2006

Delays in diagnosis and treatment of patients with smear-positive pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 689s
Year: 2005

Factors influencing time to sputum conversion in smear-positive pulmonary tuberculosis
Source: Annual Congress 2010 - Prognosis of tuberculosis
Year: 2010


Characteristics of smear-positive pulmonary tuberculosis patients with delayed diagnosis
Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection
Year: 2020


A T-cell-based assay for rapid diagnosis of difficult cases of tuberculosis (TB): smear negative pulmonary and extra-pulmonary TB
Source: Eur Respir J 2005; 26: Suppl. 49, 240s
Year: 2005

Treatment outcomes of smear positive pulmonary tuberculosis cases
Source: Eur Respir J 2005; 26: Suppl. 49, 647s
Year: 2005

Factors influencing sputum conversion among smear-positive pulmonary tuberculosis patients in Morocco
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III
Year: 2013

Bacteriologic picture of infection foci in lung resection specimens of smear-negative tuberculosis patients
Source: Eur Respir J 2004; 24: Suppl. 48, 421s
Year: 2004

Sputum induction to aid diagnosis of smear-negative or sputum-scarce tuberculosis in adults in HIV-endemic settings
Source: Eur Respir J 2014; 43: 185-194
Year: 2004



Sputum smear negative pulmonary tuberculosis (PTB) – when should the treatment be started?
Source: Eur Respir J 2006; 28: Suppl. 50, 505s
Year: 2006

A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis
Source: Annual Congress 2008 - Problems in managing pulmonary and extrapulmonary tuberculosis
Year: 2008

The rational chemotherapy of new smear-positive lung tuberculosis with extended cavitary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 9s
Year: 2006

Role of bronchoscopy in the diagnosis of pulmonary tuberculosis in sputum AFB smear negative cases
Source: Eur Respir J 2006; 28: Suppl. 50, 169s
Year: 2006

Value of bronchoscopic specimens for the diagnosis of sputum smear negative tuberculosis in high burden multidrug resistant tuberculosis setting
Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions
Year: 2012

Performance of RD-1 based blood assays in clinical management of smear-negative pulmonary and extra-pulmonary tuberculosis
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007


Effectiveness of chemotherapy in newly detected patients with pulmonary tuberculosis with poly-resistance
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010

Efficacy of standard chemotherapy regimen in patients with newly detected sputum-positive destructive pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 40s
Year: 2003

Usefulness of CT, whole-blood interferon-g assay and sputum TB-PCR in the diagnosis of smear-negative pulmonary tuberculosis
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009


Effectiveness of intravenous isoniazid and ethambutol administration in patients with new smear positive drug-susceptible pulmonary tuberculosis with tuberculous meningoencephalitis and HIV co-infection in the intensive phase of treatment
Source: International Congress 2019 – Tuberculosis: treatment and management
Year: 2019